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Summary: The preparation and evaluation of ethylene glycol-stabilized haemolysates for use äs control
material for the assay of glycated haemoglobins is described. These haemolysates were prepared from normal
and diabetic blood samples by following the procedure normally used to purify human haemoglobin, with
the addition of dialysis to remove glucose from the labile fractions, and dilution with ethylene glycol. All
the haemoglobin fractions were converted into the carbon monoxide form to increase their stability and were
stored under different conditions.
During a lOmonth period of storage at — 20 °C no significant change in the glycated haemoglobins level
was observed.
Bereitung und Prüfung von mit Ethylenglykol stabilisierten Hämolysaten zur Bestimmung glykosylierter Hämo-
globine
Zusammenfassung: Bereitung und Bewertung von mit Ethylenglykol stabilisierten Hämolysaten für den
Gebrauch als Kpntrollmaterial für die Bestimmung glykosylierter Hämoglobine werden beschrieben. Diese
Hämolysäte wurden entsprechend den zur Reinigung von menschlichem Hämoglobin verwendeten Verfahren
aus Blutproben Gesunder und von Diabetikern hergestellt. Zusätzlich wurde dialysiert, um Glucose aus den
labilen Fraktionen zu entfernen, und mit Ethylenglykol verdünnt. Alle Hämoglobinfraktionen wurden in ihre
CO-Derivate überführt, um ihre Stabilität zu erhöhen, und unter verschiedenen Bedingungen aufbewahrt.
Während zehnmqnätiger Aufbewahrung bei — 20 °C wurden keine signifikanten Änderungen der Konzentra-
tion glycosylierter Hämoglobine beobachtet.
_ * Unfortunely, no stable reference material is available.; Introduction
 A ' ' . .,N . . . .; According to a recent report (6), control data are
| The measurement of glycated haemoglobins HbAlc satisfactory only when the thiobarbituric acid test is
[ or HbAj is of great clinical importance for the long used to ineasure calibration compounds (fructose or
l term monitoring of diabetic patients (l, 2). The clin- 5-hydroxymethylfurfural), or affmity chroma-
j ical usefulness of this test is greatly enhanced when tography is used with whole blood (7) to measure the
the so called „labile" fraction, i. e. the Schiff base glycated haemoglobins. Fructose or 5-hydroxyme-
adduct between haemoglobin and glucose, is dis- thylfurfural are easily available in the laboratory.
sociated by dialysis (3), treatment with a borate buffer Although whole blood can be used directly äs control
(4), or with semicarbazide (5). material (7), it can not be stored for a long time.
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Some lyophilized Standards are now commercially
available (from Bio-Rad Laboratories and Boeh-
ringer Mannheim) but their stability after re-
constitution is very limited.
In our previous reports on quality control in hae-
moglobinometry (8) and on the measurements of
haemoglobins A2 and F (9) we described the pre-
paration of some ethylene glycol-stabilized hae-
molysates. These were shown to be stable for more
than one year when stored at — 20 °C.
In this paper, a similar technique is described for
the preparation of haemolysates for use äs control
material for the assay of glycated haemoglobins. The
following experimental steps were adopted:
a) removal of the labile fraction by incubation of the
haemolysate with an appropriate borate buffer;
b) conversion of haemoglobin to the carbon mon-
oxide derivative;
c) dilution ofthe solution with ethylene glycol and
storageat -20°C.
Materials and Methods
Preparation of the haemolysate
Haemolysates, containing normal and pathological HbAt cqn-
centrations, were prepared from blood samples from healthy
subjects (from the blood center AVIS, Milan) and from a pool
of washed red blood cells from diabetic patients, respectively.
Sodium EDTA at l g/l final concentration was used äs anti-
coagulant. No sample with abnormal values of HbA2, HbF,
HBsAg and/or abnormal haemoglobin bands on cellulose acet-
ate electrophoresis at pH 8.4 or positive for HBsAg was
included. All the purification work was performed in the cold
room.
After plasma removal, the red blood cells were washed three
times with a 9.0 g/l NaCl solution and then haemolysed by
addition of CC14 and distilled water (0.4 volumes and 1.0
volumes, respectively, per volume of red blood cells). The
haemoglobin solution was then separated after centrifugation
at 3000g for 30min and dialysed against 50mmol/l sodium
tetraborate pH 8.9. After 4 changes of the buffer, the dialysing
solution was replaced by a solution of 20 mmol/1 K2HPO4,
50 mmol/1 KC1 and 5 mmol/1 EDTA at pH 7.4. The dialysis was
complete after 4 further changes of this buffer. The resulting
haemoglobin solution was then concentrated with an Amicon
apparatus (using PM10 membranes) up to 230 g/l and flushed
with carbon monoxide in sealed vials for about 5 min.
The haemoglobin was allowed to stand overnight under an
atmosphere of CO, then centrifuged at 20000 g for 40 min to
remove any precipitated material. Finally, it was diluted with
ethylene glycol to give a total Hb concentration of about 150 g/l
in 0.35 vol/vol ethylene glycol. Small aliquots (2 ml) of this
material were then distributed in sterilized sealed vials, flushed
again with carbon monoxide and stored at — 20°C.
HbA, and HbA lc measurements
The HbA, and HbAlc levels were determined by the commercial
methods available from Bio-Rad Laboratories (Milan). All
the Chromatographie runs were performed in a thermostated
chamber at 23 ± 0.2°C.
Speclrophotometric analysis of haemoglobin sol-
utions
The HbCO and MetHb Contents of the haemoglobin Solutions
were determined by use of a multicomponent analysis pro-
gramme on the spectrophotometer Sp 601 (C. Erba, Milan).
The 10 mmol/1 borate solution at pH 9.1 used for these analyses
was prepared fresh each week.
The same Instrument was used to ofctain the haemoglobin
•spectra.
Isoelectric focusing
Isoelectric focusing (IEF) analysis of the samples was performed
on a polyacrylamide gel (12 12 0.05 cm, T = 6%, C =
4%) containing 4% of LKB ampholines (pH 6—8). The run
was performed at 5 W constant power and 800 V. Stauung was
done by the Comassie blue method äs described by Mälik (10).
Results
The HbAi and HbAlc levels of the normal and of the
diabetic haemolysates stored at — 20 °C were analysed
over a 10 month period and found to be very stable.
All the analyses were performed in duplicate on the
same vials. The stability was statistically assessed by
means of a linear regression analysis of analytical
values (y, fraction) versus time of storage (x, in days)
(11). The relevant parameters are shown in tablel.
No significant differences were found between the
overall mean values and the corresponding intercept
values. The within run precision CV for the HbAi
and HbAlc determinations were 1.7% and 2.5% re-
spectively. For the normal sample the between run
CV were 3.3% for the HbAj determinations and
7.2% for the HbAlc. For the diabetic samples they
were 2.6% and 5.0%, resp'ectively.
The IEF analysis (fig. 1) did not reveal significant
differences among the samples, before and after
about one year of storage at — 20 °C.
Tab. 1. Regression analysis parameters calculated on the data
of flgure l.
Haemolysate
Normal
Diabetic
•
Parameter
slope
SD
intercept
SD
mean
SD
slope
SD
intercept
SD
mean
SD
y = HbAt
0.000
±0.001
7.2
±0.1
7.1
±0.2
0.000
±0.001 ^
10.3
±0.1
10.2
+0.2
y = HbAlc
0.000
±0,002
4.9
±0.1
4.9
±0.3
0.000
±0.001
7.4
±0.1
7,4
±0.3
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Fig.l. Photographs of the IEF analysis on the haemolysates before and after one year of storage at -20°C.
Sample 1: freshly pfepared normal haemolysate; a) photograph taken soon after the IEF run.
sample 2: the same äs in l, one year later; b) the same slab äs in A, after staining with Comassie
sample 3: freshly prepared diabetic haemolysate; blue.
sample 4: the same äs in 3, one year later;
sample 5: oxyhaemoglobin solution partially oxidized
(50% of the haem) with ferricyanide.
By spectrophotometric analysis, the amount of
MetHb in all samples was found to be neglegible;
furthermore, no trace of haemoglobin aging com-
ponents (such äs HbA3 and other, (13)) were detected.
After staining with Comassie blue the composition
of the non-haemoglobin bands was also found to be
unchanged in all the samples.
A third preparation from non diabetic blood was
used to test the stability of HbAj and HbAlc levels
during ISdays storage at -80°C, +4°C, +25°C
and +37°C.
The results are shown in figure 2.
The HbCÖ and MetHb concentrations of the hae-
molysates stored at — 20 °C were analysed on the
same days that HbAi and HbAic measurements were
made. The HbCO and MetHb levels were found to
be stable during storage. Över 146 days of storage,
the HbCO and MetHb levels were 91.3 + 1.6% and
2.2 + 0.2% (mean ± SD), respectively.
The HbCO and MetHb were also determined in the
samples stored ai -80°C, +4°C, +25°C and +
37 °C. No significative deviations from the initial
values were reported during the period of storage.
To evaluate the possible use of this material in long
term quality control programs for HbA! and HbAlc
measurements, we stored some haemolysate at
— 80°<j. Under these conditions the solution freezes;
we think, hpwever, that the combined effect of the
ethylene glycol and the carbon monoxide can prevent
the haemoglobin from autoxidation. The effects of
repeated cycles of freezing and thawing on the same
material were therefore studied by measuring the
absorption spectra in the region 500—650 nm.
No significative changes in the initial spectrum were
detected even after 16 cycles.
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Fig. 2. HbA, (a) and H'bAlc (b) fractions in normal haemolysates stored at -80°C ( ), +4ÖC (O), +25°C (D) and + 37°C
L Clin. Chem. Clin. Biochem. / Vol. 23,1985 / No. 6
364 Mosca et al.: Ethylene glycol-stabilized haemolysates for glycated haemoglobin assay
Discussion
It is known that protein Solutions can be stabilized
in several ways. Glycerol seems to have a powerful
effect on the activity of several enzymes (12). In the
case of haemoglobin, stabilization is improved by the
use of carbon monoxide, preventing the generation
of methaemoglobin, which is rapidly formed after
exposure at relatively warm temperatures (8). Finally,
the cold is probably a third protective agent and
indeed our data demonstrate that under proper con-
ditions of storage, the haemolysates can be main-
tained for long periods of time. The treatement with
borate is particularly necessary to obtain hae-
molysates free from the „labile fractions".
A previous report by Delgado & Daza (14) described
the preparation and the control of a lyophilized hae-
molysate which proved to be stable for Smonths
after preparation. However no statistical analysis of
the stability was presented. Further, the con-
centrations during the storage were not graphically
illustrated.
We hope that the method described here will be
helpful in the production of control materials for
glycated haemoglobin assays, which is still, according
to Goldstein (15), a very actual problem for the
optimization of these analysis and for the comparison
of values from clinic to clinic. As described above,
we determined the two HbAi and HbAlc con-
centrations by means of cation exchange chro-
matography on Bio-Rex 70 on -Rad minicolumns.
Although the real accuracy of the HbAic method
could be questionable, nevertheless the two methods
are among the most commonly used in cliiiical analy-
sis. Of course, it is important to confinn our data
using pther techniques, such äs HPLC and affinity
chromatography. Work is now in progress in our
laboratory to test a fresh stock of haemolysate by
the thiobarbituric acid test and to evaluate the long
term stability of haemolysates stored at — 80 °C. The
results of these experiments will be presented in a
future communication.
The stabilized haemolysate herein described is now
being tested by a group of the Community Bureau
of Reference (Commission of the Eüiropean Com-
munities) äs suitable material for an interlaboratories
test. This test will be designed to evaluate analytical
variability in the glycated haemoglobin measurement.
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